Get to know the other members
of the Executive Board
Dr. Axel HamannChief Financial Officer (CFO)
Curriculum Vitae
Responsible for Group functions:
Controlling, Accounting & Risk
Finance
Internal Auditing
Taxes & Customs
Born 1974.
Education:
1994 - 1996: Studies of Law and Economics, University Bayreuth, Germany
1996 - 1999: First State Examination, Law, Julius-Maximilians-University of Wuerzburg, Germany
2000 - 2002: Doctor of Philosophy, PhD (Banking, Corporate, Finance & Securities Law), University of Cologne
2001 - 2003: Second State Examination, Law, Higher Regional Court OLG Duesseldorf
2008 - 2010: Executive MBA (Finance, General Management), Kellog School of Management, Northwestern University (USA)
2017: Harvard Business School, Driving Corporate Performance, Senior Executive Program
Career
2003 - 2005: Senior Associate, Hengeler Mueller
2005 - 2007: Head of Legal M&A, Bayer AG
2007 - 2010: Executive Board Support, Finance
2010 - 2014: CEO and CFO, Bayer Turkey
2014 - 2015: Global Project lead IPO and Carve-out "Covestro"
2016 - 2018: Head of Bayer Business Consulting
2019 - 2020: Project lead of the restructuring program "Bayer 2022"
2020 - 2022: CFO, Bayer Pharmaceuticals
2023 - 2025: Head of Internal Audit & Risk Management, Head of Global M&A, Bayer AG
since May 1, 2025: CFO, thyssenkrupp AG
Membership of statutory supervisory boards within the meaning of Art. 125 of the German Stock Corporation Act (AktG)
thyssenkrupp Materials Services GmbH (Chair)
thyssenkrupp Steel Europe AG
TKMS AG & Co. KGaA
TKMS Management AG